Nykode Therapeutics Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Technology:
DNA
Industry:
DNA
Headquarters:
Oslo, Oslo, Norway
Founded Date:
2007-01-01
Employees Number:
11-50
Funding Status:
Venture
Investors Number:
5
Total Funding:
36596103
Estimated Revenue:
Less than $1M
Last Funding Date:
2016-12-16
Last Funding Type:
Venture Round
Register and Claim Ownership